Sign in
4

Changes in Ownership

CRESCENT BIOPHARMA, INC. Filed Acc 0001209191-22-017963

SVP Finance, CFO sold 2,917 shares at $1.09 ($3,180)

From the SEC's structured data for this filing

Trades in this filing

Hahn Brian M. · SVP Finance, CFO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-09 Sale : show line 1 in the form −2,917 $1.09 $3,180 36,843 D
Open-market sales · 2,917 sh · avg $1.09 · $3,180
Loading xslF345X03/doc4.xml…